169 related articles for article (PubMed ID: 8602867)
21. Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro.
Hoggard PG; Sales SD; Kewn S; Sunderland D; Khoo SH; Hart CA; Back DJ
Antivir Chem Chemother; 2000 Nov; 11(6):353-8. PubMed ID: 11227992
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells.
Pan-Zhou XR; Cui L; Zhou XJ; Sommadossi JP; Darley-Usmar VM
Antimicrob Agents Chemother; 2000 Mar; 44(3):496-503. PubMed ID: 10681309
[TBL] [Abstract][Full Text] [Related]
23. Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog.
Soudeyns H; Yao XI; Gao Q; Belleau B; Kraus JL; Nguyen-Ba N; Spira B; Wainberg MA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1386-90. PubMed ID: 1929298
[TBL] [Abstract][Full Text] [Related]
24. Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3'-azido-3'-deoxythymidine (AZT).
Hiebl J; Zbiral E; Balzarini J; De Clercq E
J Med Chem; 1992 Aug; 35(16):3016-23. PubMed ID: 1323681
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase.
Liou JY; Krishnan P; Hsieh CC; Dutschman GE; Cheng YC
Mol Pharmacol; 2003 Jan; 63(1):105-10. PubMed ID: 12488542
[TBL] [Abstract][Full Text] [Related]
26. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
27. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
[TBL] [Abstract][Full Text] [Related]
28. Anti-human immunodeficiency virus type 1 (HIV-1) activity of 2'-fluoro-2',3'-dideoxyarabinosyladenine (F-ddA) used in combination with other mechanistically diverse inhibitors of HIV-1 replication.
Buckheit RW; Russell JD; Pallansch LA; Driscoll JS
Antivir Chem Chemother; 1999 May; 10(3):115-9. PubMed ID: 10431610
[TBL] [Abstract][Full Text] [Related]
29. Targeting antiviral nucleotide analogues to macrophages.
Magnani M; Rossi L; Fraternale A; Casabianca A; Brandi G; Benatti U; De Flora A
J Leukoc Biol; 1997 Jul; 62(1):133-7. PubMed ID: 9226004
[TBL] [Abstract][Full Text] [Related]
30. Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1.
Smith M; Salomon H; Wainberg MA
Clin Invest Med; 1994 Jun; 17(3):226-43. PubMed ID: 7523016
[TBL] [Abstract][Full Text] [Related]
31. Some nucleoside analogs with anti-human immunodeficiency virus activity inhibit replication of Epstein-Barr virus.
Mar EC; Chu CK; Lin JC
Antiviral Res; 1995 Sep; 28(1):1-11. PubMed ID: 8585756
[TBL] [Abstract][Full Text] [Related]
32. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
[TBL] [Abstract][Full Text] [Related]
33. Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides.
Lee TT; Kashiwada Y; Huang L; Snider J; Cosentino M; Lee KH
Bioorg Med Chem; 1994 Oct; 2(10):1051-6. PubMed ID: 7773621
[TBL] [Abstract][Full Text] [Related]
34. N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activity.
Shi J; Mathew JS; Tharnish PM; Rachakonda S; Pai SB; Adams M; Grier JP; Gallagher K; Zhang H; Wu JT; Shi G; Geleziunas R; Erickson-Viitanen S; Stuyver L; Otto MJ; Watanabe KA; Schinazi RF
Antivir Chem Chemother; 2003 Mar; 14(2):81-90. PubMed ID: 12856919
[TBL] [Abstract][Full Text] [Related]
35. [New 5'-phosphonates, modified through the nucleoside sugar residue, as inhibitors of HIV replication].
Kraevskiĭ A; Tarusova N; Zhu KIu; Vidal P; Chu TCh; Pol'ski B; Iang KIu; Matulich-Adamich Ia; Rozenberg I; Vatanabe KA
Mol Biol (Mosk); 1992; 26(3):624-34. PubMed ID: 1406617
[TBL] [Abstract][Full Text] [Related]
36. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
[TBL] [Abstract][Full Text] [Related]
37. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase.
Johnson AA; Ray AS; Hanes J; Suo Z; Colacino JM; Anderson KS; Johnson KA
J Biol Chem; 2001 Nov; 276(44):40847-57. PubMed ID: 11526116
[TBL] [Abstract][Full Text] [Related]
38. Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.
Schinazi RF; Sommadossi JP; Saalmann V; Cannon DL; Xie MY; Hart GC; Smith GA; Hahn EF
Antimicrob Agents Chemother; 1990 Jun; 34(6):1061-7. PubMed ID: 2393266
[TBL] [Abstract][Full Text] [Related]
39. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
Chen CH; Vazquez-Padua M; Cheng YC
Mol Pharmacol; 1991 May; 39(5):625-8. PubMed ID: 1851960
[TBL] [Abstract][Full Text] [Related]
40. First-line therapy and mitochondrial damage: different nucleosides, different findings.
Blanco F; García-Benayas T; José de la Cruz J; González-Lahoz J; Soriano V
HIV Clin Trials; 2003; 4(1):11-9. PubMed ID: 12577192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
